Bimatoprost vs Meloxicam: side-by-side comparison
Bimatoprost (Prostaglandin analogue) and Meloxicam (NSAID (preferential COX-2 inhibitor)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Bimatoprost | Meloxicam |
|---|---|---|
| Therapeutic class | Prostaglandin analogue | NSAID (preferential COX-2 inhibitor) |
| CAS | 155206-00-1 | 71125-38-7 |
| ATC | S01EE03 | M01AC06 |
| Molecular weight | 415.57 g/mol | 351.40 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Bimatoprost and Meloxicam share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Bimatoprost acts by a different mechanism than Meloxicam, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Bimatoprost: Le bimatoprost est un analogue des prostamides qui augmente l'écoulement de l'humeur aqueuse par le trabéculum et par la voie uvéosclérale, abaissant la pression intraoculaire. Meloxicam: Le méloxicam inhibe les cyclo-oxygénases avec une préférence pour la COX-2 aux faibles doses thérapeutiques.
Indications compared
Bimatoprost: Le bimatoprost est autorisé chez l'adulte dans le traitement de l'hypertonie oculaire et du glaucome chronique à angle ouvert. Meloxicam: Le méloxicam est autorisé chez l'adulte dans le traitement symptomatique de l'arthrose, de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante.
Safety profile
Bimatoprost: Les effets indésirables fréquents comprennent hyperhémie conjonctivale, irritation oculaire, allongement et assombrissement des cils, ainsi qu'une pigmentation progressive de l'iris, définitive. Meloxicam: Les effets indésirables fréquents comprennent troubles digestifs, œdèmes périphériques, hypertension et céphalées.
Questions fréquentes
Is Bimatoprost better than Meloxicam? ▾
Bimatoprost and Meloxicam are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Bimatoprost and Meloxicam be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Bimatoprost
Products with Meloxicam
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.